Topas

Topas is a Germany-based biotechnology company that develops and commercializes nanoparticle-based therapeutics for the treatment of autoimmune diseases and allergies.

Business Model:

Revenue: $3.5M

Employees: 11-50

Detailed Topas Information

Geographic Data

Topas headquarters map

Address: Falkenried 88

City: Hamburg

State: hamburg

Zip: 20251

Country: DE

Financial Info

Stage:

series b

Raised Last:

$21M

Raised Total:

$68M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Topas is a Germany-based biotechnology company that develops and commercializes nanoparticle-based therapeutics for the treatment of autoimmune diseases and allergies.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
3/2016 Series A $16.5M Epidarex Capital
EMBL Ventures
Gimv
Evotec
10/2020 Series B $26M Vesalius Biocapital III
BioMedPartners
Boehringer Ingelheim Venture Fund
EMBL Ventures
Epidarex Capital
Evotec
Gimv
11/2017 Series A $4.7M Boehringer Ingelheim Venture Fund
7/2021 Series B $22M BioMedPartners
Boehringer Ingelheim Venture Fund
EMBL Ventures
Epidarex Capital
Evotec
GIMV
Vesalius Biocapital III
7/2021 Series B $0 BioMedPartners
Boehringer Ingelheim Venture Fund
EMBL Ventures
Epidarex Capital
Evotec
Gimv
Vesalius Biocapital Partners
BioMedPartners
Boehringer Ingelheim Venture Fund
EMBL Ventures
Epidarex Capital
Evotec
Gimv
Vesalius Biocapital Partners
3/2016 Series A $0 EMBL Ventures
Epidarex Capital
Gimv
EMBL Ventures
Epidarex Capital
Gimv
10/2020 Series B $0 BioMedPartners
Boehringer Ingelheim Venture Fund
EMBL Ventures
Epidarex Capital
Gimv
Vesalius Biocapital Partners
BioMedPartners
Boehringer Ingelheim Venture Fund
EMBL Ventures
Epidarex Capital
Gimv
Vesalius Biocapital Partners
11/2017 Series A 1 $4.7M Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund
7/2021 Series B 7 $21.4M BioMedPartners
Boehringer Ingelheim Venture Fund
EMBL Ventures
Epidarex Capital
Evotec
Gimv
Vesalius Biocapital Partners
BioMedPartners
Boehringer Ingelheim Venture Fund
EMBL Ventures
Epidarex Capital
Evotec
Gimv
Vesalius Biocapital Partners
10/2020 Series B 6 $25.9M BioMedPartners
Boehringer Ingelheim Venture Fund
EMBL Ventures
Epidarex Capital
Gimv
Vesalius Biocapital Partners
BioMedPartners
Boehringer Ingelheim Venture Fund
EMBL Ventures
Epidarex Capital
Gimv
Vesalius Biocapital Partners
3/2016 Series A 3 $15.7M EMBL Ventures
Epidarex Capital
Gimv
EMBL Ventures
Epidarex Capital
Gimv
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research